MedTrace Logo

Lymph Fluid and Blood Collection for Identification of Novel Biomarkers

NCT01075607 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-03-28

No results posted yet for this study

Summary

The objective of this study is to identify and validate metastasis protein markers in lymph collected from women with metastatic breast cancer. We will examine peripheral blood for the presence of these identified markers in order to develop a user friendly clinical test to detect metastasis and to evaluate response to therapy.

Conditions

  • Adenocarcinoma of the Breast

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Monet Bowling, MD · Indiana University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2020-04-30
Completion
2022-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01075607 on ClinicalTrials.gov